Last updated 2026-07-23
- Raised $23M Series A led by Pontifax, May 2025
- Raised $8M Seed round led by Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Aug 2022
- Raised Pre-Seed round led by Pontifax, Dec 2019
Total raised
$31.0M
Last: Undisclosed Round 2025-06
Stage
Series A
Founded
2018
Headcount
5
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Orvida Pharma (formerly Kamari Pharma) is a privately-held clinical-stage biotechnology company focused on developing first-in-class and best-in-class treatments for rare and severe genetic skin diseases. The company's drugs are based on proprietary small molecules that modulate TRPV3, an ion channel that plays a key role in the skin. Orvida's lead programs, KM-001 (topical) and KM-023 (oral, also known as Ontivatrep), are novel, highly specific, and selective TRPV3 inhibitors being developed to treat conditions such as Olmsted syndrome, severe keratoderma, ichthyosis, and Lichen Simplex Chronicus.
Funding history · 3 rounds · $31.0M total
2025-05
A Round
$23.0M
★ Pontifax★ BRM Group
2022-08
Seed
$8.0M
★ Guangzhou Sino-Israel Biotech Investment Fund (GIBF)
2019-12
Pre-Seed
Undisclosed
★ Pontifax★ Arkin Bio
Headcount over time
From 6 (2022-10) to 13 (2026-07) · +7 (+117%) · 8 points · source: Finder history + radar grounding
Q&A
- What is Kamari Pharma's primary focus?
- Kamari Pharma is a biopharmaceutical company focused on developing and commercializing proprietary small molecule inhibitors of TRPV3 for the treatment of dermatological conditions.
- When was Kamari Pharma founded?
- Kamari Pharma was founded in October 2018.
- What is Kamari Pharma's employee count?
- Kamari Pharma has 1-10 employees.
- What is the total funding raised by Kamari Pharma to date?
- Kamari Pharma has raised a total of $31,000,000 USD.
- Which investors participated in Kamari Pharma's funding round in September 2022?
- Guangzhou Sino-Israel Biotech Investment Fund (GIBF) participated in Kamari Pharma's $8,000,000 funding round in September 2022.
- Which investors led Kamari Pharma's most recent funding round in June 2025?
- Pontifax and BRM Group led Kamari Pharma's $23,000,000 funding round in June 2025.
- What is the current stage of Kamari Pharma's product development?
- Kamari Pharma's product is currently in the R&D stage.
- Does Kamari Pharma hold any patents?
- Yes, Kamari Pharma holds 1 patent.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
biopharmaceuticaldrug-developmentdermatologypharma-companiesskinrare-diseasespharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | orvidapharma.com |
|---|---|
| linkedin.com/company/83017944 | |
| Wikidata | wikidata.org/wiki/Q140045564 |
Identifiers & details
| Legal name | Orvida Pharma Ltd. |
|---|---|
| Founded | 2018-10 |
| Employees (exact) | 5 |
| Wikidata QID | Q140045564 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | orvidapharma.com |
|---|
Wikidata
| QID | Q140045564 |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515880847 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-07-26 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 2 |
| Registry events | 5 — name_change (1), charge (2), shares_capital (2) |
| Name changes | 2026-03-25 |
| Registered address | ספיר פנחס 3 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-25 | שינוי שם |
| 2026-04-20 | רישום שעבוד |
| 2026-04-20 | רישום שעבוד |
| 2026-06-14 | שינוי בהרכב הון - מניות-הפחתת הון מוקצה |
| 2026-06-11 | הקצאת מניות |